Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Junichi Azuma

Showing results (71-80 of 134) with videos related to

Pageof 14
Sort By:
The Biochemical Journal|December 2, 2005
Myogenic differentiation induces taurine transporter in association with taurine-mediated cytoprotection in skeletal musclesYoriko Uozumi, Takashi Ito, Yuki Hoshino, et al.
Biological & Pharmaceutical Bulletin|November 6, 2007
Nonlinear mixed effects model analysis of the pharmacokinetics of aripiprazole in healthy Japanese malesToshiko Koue, Masanori Kubo, Tomoo Funaki, et al.
The Biochemical Journal|May 15, 2004
Expression of taurine transporter is regulated through the TonE (tonicity-responsive element)/TonEBP (TonE-binding protein) pathway and contributes to cytoprotection in HepG2 cellsTakashi Ito, Yasushi Fujio, Mayo Hirata, et al.
Biochimica Et Biophysica Acta|July 29, 2004
Pioglitazone induces plasma platelet activating factor-acetylhydrolase and inhibits platelet activating factor-mediated cytoskeletal reorganization in macrophageChinuyo Sumita, Makiko Maeda, Yasushi Fujio, et al.
Advances in Experimental Medicine and Biology|August 12, 2003
Modulation of taurine on CYP3A4 induction by rifampicin in a HepG2 cell lineKyoko Takahashi, Hideyasu Matsuda, Kayoko Kinoshita, et al.
Clinical Pharmacology and Therapeutics|November 23, 2006
Warfarin dose requirement for patients with both VKORC1 3673A/A and CYP2C9*3/*3 genotypesTsuyoshi Fukuda, Tomoko Tanabe, Masako Ohno, et al.
Molecular Pharmacology|April 19, 2007
Regulation of cytochrome P450 2E1 under hypertonic environment through TonEBP in human hepatocytesTakashi Ito, Koko Asakura, Katsuhiko Tougou, et al.
Nihon Shinkei Seishin Yakurigaku Zasshi = Japanese Journal of Psychopharmacology|March 31, 2009
[5-HT1A gene polymorphisms contributed to antidepressant response in major depression]Masaki Kato, Takeshi Fukuda, Masaki Wakeno, et al.
Brain Research. Molecular Brain Research|October 8, 2004
Effect of genetic polymorphism on the metabolism of endogenous neuroactive substances, progesterone and p-tyramine, catalyzed by CYP2D6Toshiro Niwa, Toyoko Hiroi, Daisuke Tsuzuki, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|October 23, 2010
Cigarette smoke extract induces CYP2B6 through constitutive androstane receptor in hepatocytesIkumi Washio, Makiko Maeda, Chika Sugiura, et al.
Pageof 14

Showing results (71-80 of 134) with videos related to

Sort By:
Pageof 14
The Biochemical Journal|December 2, 2005
Myogenic differentiation induces taurine transporter in association with taurine-mediated cytoprotection in skeletal musclesYoriko Uozumi, Takashi Ito, Yuki Hoshino, et al.
Biological & Pharmaceutical Bulletin|November 6, 2007
Nonlinear mixed effects model analysis of the pharmacokinetics of aripiprazole in healthy Japanese malesToshiko Koue, Masanori Kubo, Tomoo Funaki, et al.
The Biochemical Journal|May 15, 2004
Expression of taurine transporter is regulated through the TonE (tonicity-responsive element)/TonEBP (TonE-binding protein) pathway and contributes to cytoprotection in HepG2 cellsTakashi Ito, Yasushi Fujio, Mayo Hirata, et al.
Biochimica Et Biophysica Acta|July 29, 2004
Pioglitazone induces plasma platelet activating factor-acetylhydrolase and inhibits platelet activating factor-mediated cytoskeletal reorganization in macrophageChinuyo Sumita, Makiko Maeda, Yasushi Fujio, et al.
Advances in Experimental Medicine and Biology|August 12, 2003
Modulation of taurine on CYP3A4 induction by rifampicin in a HepG2 cell lineKyoko Takahashi, Hideyasu Matsuda, Kayoko Kinoshita, et al.
Clinical Pharmacology and Therapeutics|November 23, 2006
Warfarin dose requirement for patients with both VKORC1 3673A/A and CYP2C9*3/*3 genotypesTsuyoshi Fukuda, Tomoko Tanabe, Masako Ohno, et al.
Molecular Pharmacology|April 19, 2007
Regulation of cytochrome P450 2E1 under hypertonic environment through TonEBP in human hepatocytesTakashi Ito, Koko Asakura, Katsuhiko Tougou, et al.
Nihon Shinkei Seishin Yakurigaku Zasshi = Japanese Journal of Psychopharmacology|March 31, 2009
[5-HT1A gene polymorphisms contributed to antidepressant response in major depression]Masaki Kato, Takeshi Fukuda, Masaki Wakeno, et al.
Brain Research. Molecular Brain Research|October 8, 2004
Effect of genetic polymorphism on the metabolism of endogenous neuroactive substances, progesterone and p-tyramine, catalyzed by CYP2D6Toshiro Niwa, Toyoko Hiroi, Daisuke Tsuzuki, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|October 23, 2010
Cigarette smoke extract induces CYP2B6 through constitutive androstane receptor in hepatocytesIkumi Washio, Makiko Maeda, Chika Sugiura, et al.
Pageof 14